| NAV | $9.06 | Daily Change | $0.04 | 0.44% |
| Market Price | $8.97 | Daily Change | $0.04 | 0.45% |
The global telemedicine market increased over 8% from 2022 to 2023, exceeding $94bn. Forecasts suggest the market could reach over $286bn by 2028.1
AI could be the missing link to achieve transformative digitization in the Health Care sector. In the U.S. alone, it's estimated that AI could save as much as 10% of annual health care spending.2
Following success in diabetic monitoring, wearables are expanding into cardiovascular care. The potential market could be enormous, as an estimated 33mm people have atrial fibrillation3 and some 1.28bn adults have hypertension.4
1Fortune Business Insights, Jul 2023
2National Bureau of Economic Research, Jan 2023
3Frontiers in Public Health, Jun 2023
4World Health Organization, Mar 2023
| Inception Date | 07/29/20 |
| Total Expense Ratio | 0.68% |
| Net Assets | $44.03 million |
| NAV | $9.06 |
| Fact Sheet | View the document |
The Global X Telemedicine & Digital Health ETF (EDOC) seeks to invest in companies positioned to benefit from further advances in the field of telemedicine and digital health. This includes companies involved in Telemedicine, Health Care Analytics, Connected Health Care Devices, and Administrative Digitization.
The Global X Telemedicine & Digital Health ETF (EDOC) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Telemedicine & Digital Health Index.
| Ticker | EDOC |
| Bloomberg Index Ticker | SOLEDOC |
| CUSIP | 37954Y285 |
| ISIN | US37954Y2853 |
| Primary Exchange | Nasdaq |
| Shares Outstanding | 4,860,000 |
| Number of Holdings | 41 |
| 30-Day Median Bid-Ask Spread | 1.00% |
| 30-Day SEC Yield | 0.40% |
| Distribution Frequency | Semi-Annually |
| NAV | $9.06 | Daily Change | $0.04 | 0.44% |
| Market Price | $8.97 | Daily Change | $0.04 | 0.45% |
|
As of recent month & quarter-end (06/30/24)
As of recent month & quarter-end (06/30/24)
|
Fund NAV | Market Price | Index |
|---|---|---|---|
| 1 Year | -24.53% | -24.76% | -24.02% |
| 3 Years | -23.02% | -23.18% | -22.69% |
| Since Inception | -13.04% | -13.17% | -12.62% |
| 1 Year | -24.53% | -24.76% | -24.02% |
| 3 Years | -23.02% | -23.18% | -22.69% |
| Since Inception | -13.04% | -13.17% | -12.62% |
| Year-to-Date | -13.39% | -13.54% | -13.05% |
| 1 Month | -2.98% | -3.42% | -2.93% |
| 3 Months | -7.85% | -7.99% | -7.63% |
| Since Inception | -42.20% | -42.53% | -41.09% |
| Year-to-Date | -13.39% | -13.54% | -13.05% |
| 1 Month | -2.98% | -3.42% | -2.93% |
| 3 Months | -7.85% | -7.99% | -7.63% |
| Since Inception | -42.20% | -42.53% | -41.09% |
Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.
The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.
| Net Assets (%) | Ticker | Name | SEDOL | Market Price ($) | Shares Held | Market Value ($) |
|---|---|---|---|---|---|---|
| 4.83 | HIMS | HIMS & HERS HEALTH INC | BN46048 | 22.84 | 93,065 | 2,125,604.60 |
| 4.71 | TWST | TWIST BIOSCIENCE CORP | BGKG6G7 | 56.15 | 36,908 | 2,072,384.20 |
| 4.70 | PODD | INSULET CORP | B1XGNW4 | 198.87 | 10,408 | 2,069,838.96 |
| 4.70 | DOCS | DOXIMITY INC-CLASS A | BMD22Y4 | 28.46 | 72,723 | 2,069,696.58 |
| 4.60 | TNDM | TANDEM DIABETES CARE INC | BF3W461 | 47.30 | 42,807 | 2,024,771.10 |
| 4.42 | RMD | RESMED INC | 2732903 | 205.31 | 9,476 | 1,945,517.56 |
| 4.15 | DGX | QUEST DIAGNOSTICS INC | 2702791 | 144.59 | 12,636 | 1,827,039.24 |
| 3.98 | QGEN | QIAGEN N.V. | BMGBZP0 | 41.80 | 41,867 | 1,750,040.60 |
| 3.94 | LH | LABCORP HOLDINGS INC | BSBK800 | 207.49 | 8,367 | 1,736,068.83 |
| 3.76 | A | AGILENT TECHNOLOGIES INC | 2520153 | 131.01 | 12,642 | 1,656,228.42 |
| 3.75 | ILMN | ILLUMINA INC | 2613990 | 116.56 | 14,150 | 1,649,324.00 |
| 3.70 | IQV | IQVIA HOLDINGS INC | BDR73G1 | 225.89 | 7,211 | 1,628,892.79 |
| 3.59 | OSCR | OSCAR HEALTH -A | BKY83Q6 | 16.00 | 98,848 | 1,581,568.00 |
| 3.43 | 6618 HK | JD HEALTH | BMW8R04 | 2.76 | 546,500 | 1,508,643.55 |
| 3.35 | IRTC | IRHYTHM TECHNOLOGIES INC | BYT4ST5 | 98.60 | 14,940 | 1,473,084.00 |
| 3.24 | DXCM | DEXCOM INC | B0796X4 | 113.01 | 12,604 | 1,424,378.04 |
| 3.17 | MASI | MASIMO CORP | B1YWR63 | 108.88 | 12,800 | 1,393,664.00 |
| 3.16 | 241 HK | ALIBABA HEALTH | BRXVS60 | 0.41 | 3,363,400 | 1,391,650.70 |
| 2.96 | AMN | AMN HEALTHCARE | 2813552 | 51.77 | 25,131 | 1,301,031.87 |
| 2.92 | RCM | R1 RCM INC | BP2S437 | 12.79 | 100,625 | 1,286,993.75 |
| 2.78 | PRVA | PRIVIA HEALTH GROUP INC | BMDP209 | 17.96 | 68,023 | 1,221,693.08 |
| 2.60 | EVH | EVOLENT HEALTH INC - A | BYLY8H1 | 19.26 | 59,434 | 1,144,698.84 |
| 2.51 | VCYT | VERACYTE INC | BFTWZY0 | 22.59 | 48,925 | 1,105,215.75 |
| 2.35 | TDOC | TELADOC HEALTH INC | BYQRFY1 | 9.26 | 111,763 | 1,034,925.38 |
| 1.82 | PHR | PHREESIA INC | BKF9DQ8 | 22.82 | 35,107 | 801,141.74 |
| 1.79 | OMCL | OMNICELL INC | 2789523 | 26.44 | 29,733 | 786,140.52 |
| 1.05 | 1833 HK | PING AN HEALTHCA | BDRYVB3 | 1.33 | 347,300 | 461,797.24 |
| 0.96 | GDRX | GOODRX HOLDIN-A | BMTVQT8 | 8.31 | 50,705 | 421,358.55 |
| 0.96 | DH | DEFINITIVE HEALT | BMGSDK2 | 5.50 | 76,509 | 420,799.50 |
| 0.80 | 4480 JP | MEDLEY INC | BK93ZN7 | 26.41 | 13,353 | 352,696.82 |
| 0.72 | 4483 JP | JMDC INC | BK7C5Q9 | 23.19 | 13,608 | 315,559.07 |
| 0.71 | LFST | LIFESTANCE HEALT | BN0TRB7 | 5.48 | 57,038 | 312,568.24 |
| 0.69 | COP GR | COMPUGROUP MEDIC | BMY7CH1 | 17.34 | 17,621 | 305,481.97 |
| 0.64 | FLGT | FULGENT GENETICS INC | BYQBFQ5 | 21.26 | 13,239 | 281,461.14 |
| 0.63 | PACB | PACIFIC BIOSCIEN | B4N8MH9 | 1.62 | 171,355 | 277,595.10 |
| 0.42 | 228760 KS | GENOMICTREE INC | BYNNYF6 | 16.27 | 11,347 | 184,637.50 |
| 0.39 | TALK | TALKSPACE INC | BP7L970 | 2.16 | 80,248 | 173,335.68 |
| 0.39 | DCGO | DOCGO INC | BKP4P23 | 3.11 | 55,702 | 173,233.22 |
| 0.32 | SENS | SENSEONICS HOLDINGS INC | BYQNYR5 | 0.47 | 306,535 | 142,538.78 |
| 0.31 | LFMD | LIFEMD INC | BMXDBQ2 | 6.69 | 20,519 | 137,272.11 |
| 0.08 | GRAL | GRAIL INC | BSLSSX7 | 15.59 | 2,356 | 36,722.25 |
| 0.03 | OTHER PAYABLE & RECEIVABLES | 1.00 | 13,942 | 13,941.85 | ||
| 0.01 | CASH | 1.00 | 3,242 | 3,242.49 | ||
| 0.00 | AUSTRALIAN DOLLAR | 0.68 | 837 | 567.04 | ||
| 0.00 | EURO | 1.09 | 1 | 1.05 | ||
| 0.00 | HONG KONG DOLLAR | 0.13 | 4 | 0.51 | ||
| 0.00 | TAIWAN DOLLAR | 0.03 | 1 | 0.03 |
| Sector | Weight (%) | |
|---|---|---|
| Health Care | 88.5 | |
| Consumer Staples | 7.8 | |
| Financials | 3.7 |
| Industry | Weight (%) | |
|---|---|---|
| Health Care | 64.8 | |
| Life Sciences Tools & Services | 15.9 | |
| Retail | 8.1 | |
| Biotechnology | 7.4 | |
| Insurance | 3.8 |
| Country | Weight (%) | |
|---|---|---|
| United States | 84.7 | |
| China | 4.8 | |
| Netherlands | 4.2 | |
| Hong Kong | 3.3 | |
| Japan | 1.4 | |
| Germany | 1.1 | |
| South Korea | 0.5 |
All Sector, Industry and Geographic breakdowns, where provided, are based on equity positions held by the ETF and exclude cash, currencies, and other holdings.
Investing involves risk, including the possible loss of principal. The investable universe of companies in which EDOC may invest may be limited. The Fund invests in securities of companies engaged in the Health Care and Information Technology sectors. These sectors can be affected by government regulations, rapid product obsolescence, intense industry competition and loss or impairment of patents or intellectual property rights. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. EDOC is non-diversified.
Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.
Since the Fund’s shares did not trade in the secondary market until several days after the Fund’s inception, for the period from inception to the first day of secondary market trading in Shares, the NAV of the Fund is used to calculate market returns.
Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.
Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Solactive AG, nor does Solactive AG make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Solactive AG.